Our Team

Farragut’s team of knowledgeable professionals is highly experienced in healthcare policy and in dealing with institutional investors, healthcare corporates, and bankers and lenders.

Our Washington D.C. analysts have held leadership positions on key U.S. Congressional healthcare committees, and helped craft seminal legislation for the Medicare Modernization Act and the Affordable Care Act. In addition, they have held senior positions at health insurance companies, providers and advocacy organizations, and worked on key regulatory issues – federal, state and/or payer-oriented. They also have experience representing the interests of hospitals, post-acute facilities, other healthcare services platforms, and pharmaceutical companies before the Centers for Medicare & Medicaid Services (CMS), Federal Drug Administration (FDA), and other federal and state regulators. In those roles, our professionals also drafted regulatory and legislative language, and developed extensive networks in Medicare, Medicaid and the payer sector.

Our New York team has extensive experience helping institutional healthcare investors interpret and anticipate complex rulemakings and shifting federal, state and payer regulatory landscapes. Leveraging their respective backgrounds in capital markets, equity sales and trading, banking and corporate strategy at major Wall Street firms, they bring a real-world perspective to our research, operations and execution related advice.